Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy

Background: Immune checkpoint inhibitor efficacy in advanced cancer patients remains difficult to predict. Imaging is the only technique available that can non-invasively provide whole body information of a patient's response to treatment. We hypothesize that quantitative whole-body prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Trebeschi, Stefano, Bodalal, Zuhir, van Dijk, Nick, Boellaard, Thierry N., Apfaltrer, Paul, Tareco Bucho, Teresa M., Nguyen-Kim, Thi Dan Linh, van der Heijden, Michiel S., Aerts, Hugo J. W. L., Beets-Tan, Regina G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056079/
https://www.ncbi.nlm.nih.gov/pubmed/33889546
http://dx.doi.org/10.3389/fonc.2021.637804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056079/
https://www.ncbi.nlm.nih.gov/pubmed/33889546
http://dx.doi.org/10.3389/fonc.2021.637804

Ejemplares similares